Myocarditis with checkpoint inhibitor immunotherapy: case report of late gadolinium enhancement on cardiac magnetic resonance with pathology correlate

BACKGROUND: Nivolumab is a human IgG4 anti-programmed cell death protein-1 (PD-1) monoclonal antibody that works by augmenting the immune response against tumour cells. It has the potential of causing multiple autoimmune-related events, including cardiac. However, the real incidence and diagnosis of...

Descripción completa

Detalles Bibliográficos
Autores principales: Gallegos, Cesia, Rottmann, Douglas, Nguyen, Vinh Q, Baldassarre, Lauren A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6439394/
https://www.ncbi.nlm.nih.gov/pubmed/31020225
http://dx.doi.org/10.1093/ehjcr/yty149

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6439394/
https://www.ncbi.nlm.nih.gov/pubmed/31020225
http://dx.doi.org/10.1093/ehjcr/yty149

Ejemplares similares